Literature DB >> 11099736

Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients.

R J Baldessarini1, L Tondo, G Floris, J Hennen.   

Abstract

INTRODUCTION: Rapid cycling (RC) in bipolar disorders is widely believed to predict future morbidity and poor treatment response, although empirical testing of its predictive utility remains limited.
METHODS: In 360 DSM-IV bipolar I (N=218) and II (N=142) disorder subjects (64% women) followed over an average of 13.3 years, we evaluated factors associated with RC status with bivariate and multivariate techniques, and response to lithium maintenance treatment (recurrence rates, time ill, survival analysis of time to recurrence on lithium).
RESULTS: RC risk (15.6% of cases) was 5. 1-times greater in bipolar II vs. I subjects (30.3%/6.0%), in minor excess in women vs. men (17.9%/11.5%), and associated with premorbid cyclothymia, depressive first episodes, older onset age, and being employed or married. Before lithium, RC vs. non-RC cases had more mean total (3.9/1.2), manic, and depressive episodes/year, and greater percent time ill (60%/38%). During treatment, prior RC status was unrelated to time to first recurrence and other measures of morbidity and improvement including percent time ill, although depressive episodes were 2.7-times more frequent, and there was 13.7% less chance of full protection from all recurrences in RC cases. LIMITATIONS: The study is naturalistic, without random assignment or blind assessment.
CONCLUSIONS: The RC bipolar subtype was strongly associated with type II diagnosis, higher average prelithium episode frequency and percent time ill, and weakly with female sex, but not with greater overall morbidity during treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11099736     DOI: 10.1016/s0165-0327(99)00196-2

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  15 in total

1.  Diagnosis and treatment of rapidly cycling bipolar disorder.

Authors:  M Maj
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2001       Impact factor: 5.270

2.  Socio-demographic and clinical characterization of patients with Bipolar Disorder I vs II: a Nationwide Italian Study.

Authors:  A Carlo Altamura; Massimiliano Buoli; Bruno Cesana; Bernardo Dell'Osso; Gianluigi Tacchini; Umberto Albert; Andrea Fagiolini; Andrea de Bartolomeis; Giuseppe Maina; Emilio Sacchetti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-01       Impact factor: 5.270

Review 3.  Treatment research in bipolar disorder: issues and recommendations.

Authors:  Ross J Baldessarini
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 4.  Rapid cycling bipolar disorder: clinical characteristics and treatment options.

Authors:  William Coryell
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 5.  Rapid cycling bipolar disease: new concepts and treatments.

Authors:  S L Dubovsky
Journal:  Curr Psychiatry Rep       Date:  2001-12       Impact factor: 5.285

6.  Rapid cycling bipolar disorders in primary and tertiary care treated patients.

Authors:  Tomas Hajek; Margaret Hahn; Claire Slaney; Julie Garnham; Joshua Green; Martina Růzicková; Peter Zvolský; Martin Alda
Journal:  Bipolar Disord       Date:  2008-06       Impact factor: 6.744

Review 7.  Women and bipolar disorder across the life span.

Authors:  Dorothy Sit
Journal:  J Am Med Womens Assoc (1972)       Date:  2004

8.  Management of Bipolar II Disorder.

Authors:  Michael M C Wong
Journal:  Indian J Psychol Med       Date:  2011-01

9.  Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.

Authors:  Wayne Macfadden; Caleb M Adler; Ibrahim Turkoz; John T Haskins; Norris Turner; Larry Alphs
Journal:  BMC Psychiatry       Date:  2011-10-28       Impact factor: 3.630

10.  Stability of lithium treatment in bipolar disorder - long-term follow-up of 346 patients.

Authors:  Anne Berghöfer; Martin Alda; Mazda Adli; Christopher Baethge; Michael Bauer; Tom Bschor; Paul Grof; Bruno Müller-Oerlinghausen; Janusz K Rybakowski; Alexandra Suwalska; Andrea Pfennig
Journal:  Int J Bipolar Disord       Date:  2013-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.